Jerini Report issue

Contributed to NME For profit Phase 1 Phase 3
Founded: Berlin Germany (1994)
Status: Acquired by Shire (2008) → now Takeda (2018)

Organization Overview

First Clinical Trial
2007
NCT00536016
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Jerini AG | Jerini Ophthalmic